Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
Q9UNU6
UPID:
CP8B1_HUMAN
Alternative names:
7-alpha-hydroxy-4-cholesten-3-one 12-alpha-hydroxylase; CYPVIIIB1; Cytochrome P450 8B1; Sterol 12-alpha-hydroxylase
Alternative UPACC:
Q9UNU6; B2RCY3; O75958; Q6NWT2; Q6NWT3
Background:
7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase, also known as Cytochrome P450 8B1, plays a crucial role in primary bile acid biosynthesis. It catalyzes the 12alpha-hydroxylation of 7alpha-hydroxy-4-cholesten-3-one, a key step in cholic acid synthesis. This enzyme is essential for maintaining the biliary balance of cholic acid and chenodeoxycholic acid, which is vital for the intestinal absorption of dietary lipids.
Therapeutic significance:
Understanding the role of 7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase could open doors to potential therapeutic strategies.